62596-65-0

Basic information

• Product Name: Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-
• Synonyms: Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-;S-2-(1-Methylethyl)-1-[(4-Methylphenyl) sulfonyl]-Aziridine;(S)-2-Isopropyl-1-[(4-methylphenyl)sulfonyl]aziridine;(S)-2-Isopropyl-1-[(4-methylphenyl)sulfonyl]aziridine,99%e.e.;(2S)-2-(1-methylethyl)-1-[(4- methylphenyl)sulfonyl]-Aziridine
• CAS NO: 62596-65-0
• Molecular Formula: C₁₂H₁₇NO₂S
• Molecular Weight: 239.33388
• Mol File: 62596-65-0.mol
• Article Data: 22

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-(62596-65-0)
• EPA Substance Registry System: Aziridine,2-(1-Methylethyl)-1-[(4-Methylphenyl)sulfonyl]-, (2S)-(62596-65-0)

Safety Data

• Hazardous Substances Data: 62596-65-0(Hazardous Substances Data)

Upstream product

• 55424-48-1 (S)-2-(4-methylphenylsulfonylamino)-1-(4-methylsulfonyloxy)-3-methylbutane 
• 145624-62-0 (2S,4S)-4-isopropyl-2-p-toluene-4,5-dihydro-<1,2λ⁶,3>oxathiazole 2-oxide 
• 139192-48-6 (S)-N-(1-hydroxy-3-methylbutan-2-yl)-4-methylbenzenesulfonamide 
• 2026-48-4 (S)-valinol 
• 98-59-9 p-toluenesulfonyl chloride 
• 72-18-4 L-valine 
• 17360-25-7 N-(p-toluenesulfonyl)-L-valine 
• 10439-23-3 4-methylbenzenesulfinyl chloride 
• 92686-82-3 (S)-O-trimethylsilyl-valinol 
• 145624-61-9 4-Methyl-benzenesulfinic acid ((S)-2-methyl-1-trimethylsilanyloxymethyl-propyl)-amide 
• 51220-85-0 Methyl (S)-N-<(4-methylphenyl)sulfonyl>valinate 
• 6306-52-1 L-valine methylester hydrochloride 

Downstream Products

• 106753-61-1 4-Methyl-N-{(S)-2-methyl-1-[1-phenyl-eth-(E)-ylideneaminooxymethyl]-propyl}-benzenesulfonamide 
• 203207-80-1 N-[(R)-1-Isopropyl-5,5-dimethoxy-3-(toluene-4-sulfonyl)-pentyl]-4-methyl-benzenesulfonamide 
• 219639-02-8 (S)-N-(1-mercapto-3-methylbutan-2-yl)-4-methylbenzenesulfonamide 
• 362495-78-1 [2S,4R,1'S,2'S]-(+)-N,2,5-trimethyl-N-(2'-phenyl-2'-hydroxy-1'-methylethyl)-4-(p-toluenesulfonylamino)hexanamide 
• 406937-99-3 4-methyl-N-[(1R)-2-methyl-1-(2-thienylmethyl)propyl]benzenesulfonamide 
• 406938-00-9 N-[(1R)-1-benzyl-2-methylpropyl]-4-methylbenzenesulfonamide 
• 131078-72-3 4-methyl-N-((1S)-2-methyl-1-{[((2S)-3-methyl-2-{[(4-methylphenyl)sulfonyl]amino}butyl)amino]methyl}propyl)benzenesulfonamide 
• 462119-75-1 N-{(1S)-2-[benzyl((2S)-3-methyl-2-{[(4-methylphenyl)sulfonyl]amino}butyl)amino]-1-methylethyl}-4-methylbenzenesulfonamide 
• 460743-50-4 ((1S)-1-{[benzyl((2S)-3-methyl-2-{[(4-methylphenyl)sulfonyl]amino}butyl)amino]methyl}-2-methylpropyl)-4-methylbenzenesulfonamide 
• 142745-23-1 [(1S)-1-(aminomethyl)-2-methylpropyl]-4-methylbenzenesulfonamide 

Relevant articles and documents

Synthesis of tubuvaline (Tuv) fragment of tubulysin via diastereoselective dihydroxylation of homoallylamine

Tubulysins are natural anticancer molecules that directly bind and inhibit tubulin polymerization in actively dividing cells leading to apoptosis and cell death. Structurally, tubulysins are linear tetrapeptides, constituted by a natural amino acid (Ile)

Synthesis of the Deacetoxytubuvaline Fragment of Pretubulysin and its Lipophilic Analogues for Enhanced Permeability in Cancer Cell Lines

In the last two decades, tubulysins have emerged as alternatives to microtubule depolymerizing agents such as colchicine and vinblastine, which are well-established anticancer agents. However, the complex structure of tubulysins has always posed a challen

An efficient synthetic approach for N-C bond formation from (S)-amino acids: An easy access to cis-2,5-disubstituted chiral piperazines

An efficient synthetic strategy is described for the construction of amino acids derived enantiomerically pure cis-2,5-disubstituted chiral piperazines. Cu-catalyzed spontaneous regioselective ring opening and ring closing of non-activated N-tosyl aziridines as well as Pd-mediated N-C bond formation from N-tosyl halogenated amino-derivatives are the key steps for accessing disubstituted piperazines.